Answers are grounded in this paper and cite their sources.
BACKGROUND: Isoniazid resistant, rifampicin-susceptible tuberculosis (Hr-TB) is associated with poorer outcomes than drug-susceptible disease. Although the World Health Organization (WHO) recommends rifampicin, ethambutol, pyrazinamide, and a fluoroquinolone for Hr-TB treatment, the optimal duration of pyrazinamide remains uncertain because supporting evidence is largely observational. We described outcomes of fluoroquinolone-containing regimens limiting pyrazinamide to the intensive phase in a real-world cohort. METHODS: We conducted a retrospective cohort study of consecutive treatment episodes of pulmonary Hr-TB treatment managed in a TB referral center in Italy, between 2010 and 2025. The index regimen consisted of rifampicin, ethambutol, pyrazinamide, and a fluoroquinolone for 2 months followed by rifampicin, ethambutol, and a fluoroquinolone (2RZEFq/4-7REFq). Treatment outcomes were classified according to WHO definitions. Outcomes and adverse events were compared with those of episodes receiving alternative fluoroquinolone-containing regimens. RESULTS: Eighty-seven treatment episodes in 83 patients were included. Median age was 41 years (IQR, 29-50), 43.7% were female, and 8.0% were living with HIV. Overall treatment success was achieved in 85 of 87 episodes (97.7%). All 38 episodes treated with the index 2RZEFq/4-7REFq regimen achieved treatment success, compared with 47 of 49 (95.9%) receiving alternative regimens (Fisher exact P = .50). Overall median total treatment duration was 9 months (IQR, 8-9). Adverse events occurred in 15 of 87 episodes (17.2%) and were similar between treatment groups (13.2% vs. 20.4%; P = .41). CONCLUSIONS: Treatment success was high overall and among patients treated with 2 months of pyrazinamide followed by a fluoroquinolone-containing regimen. Further comparative studies are needed to confirm these hypothesis-generating findings.
No takes yet. Share an insight, caveat, or question.
Riccardi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: